Alcon Stock-Based Compensation 2019-2025 | ALC
Alcon annual/quarterly stock-based compensation history and growth rate from 2019 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- Alcon stock-based compensation for the quarter ending March 31, 2025 was $39M, a 9.3% decline year-over-year.
- Alcon stock-based compensation for the twelve months ending March 31, 2025 was $380M, a 2.7% increase year-over-year.
- Alcon annual stock-based compensation for 2024 was $0.15B, a 4.17% increase from 2023.
- Alcon annual stock-based compensation for 2023 was $0.144B, a 2.86% increase from 2022.
- Alcon annual stock-based compensation for 2022 was $0.14B, a 1.45% increase from 2021.
| Alcon Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $150 |
| 2023 | $144 |
| 2022 | $140 |
| 2021 | $138 |
| 2020 | $105 |
| 2019 | $83 |
| 2018 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $42.434B | $9.911B |
| Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $180.276B | 21.81 |
| Intuitive Surgical (ISRG) | United States | $171.420B | 71.05 |
| IDEXX Laboratories (IDXX) | United States | $52.185B | 54.31 |
| Edwards Lifesciences (EW) | United States | $45.166B | 29.93 |
| IQVIA Holdings (IQV) | United States | $31.605B | 17.86 |
| DexCom (DXCM) | United States | $31.439B | 47.16 |
| Mettler-Toledo (MTD) | United States | $26.632B | 31.61 |
| STERIS (STE) | Ireland | $24.008B | 25.55 |
| Waters (WAT) | United States | $16.995B | 23.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.710B | 0.00 |
| Hologic (HOLX) | United States | $15.113B | 16.37 |
| Penumbra (PEN) | United States | $9.693B | 70.81 |
| Sysmex ADR (SSMXY) | Japan | $8.813B | 28.00 |
| Globus Medical (GMED) | United States | $8.376B | 19.27 |
| Masimo (MASI) | United States | $8.156B | 27.45 |
| Teleflex (TFX) | United States | $5.287B | 8.53 |
| Glaukos (GKOS) | United States | $5.124B | 0.00 |
| TransMedics (TMDX) | United States | $4.470B | 67.94 |
| Integer Holdings (ITGR) | United States | $3.760B | 18.76 |
| LivaNova (LIVN) | United Kingdom | $2.765B | 15.82 |
| Alphatec Holdings (ATEC) | United States | $2.326B | 0.00 |
| Veracyte (VCYT) | United States | $2.263B | 31.27 |
| PROCEPT BioRobotics (PRCT) | United States | $2.148B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.073B | 24.75 |
| Artivion (AORT) | United States | $2.069B | 104.40 |
| Elekta AB (EKTAY) | Sweden | $1.879B | 16.90 |
| Integra LifeSciences Holdings (IART) | United States | $1.073B | 6.15 |
| OPKO Health (OPK) | United States | $1.048B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| IRadimed (IRMD) | United States | $0.929B | 45.06 |
| Tandem Diabetes Care (TNDM) | United States | $0.750B | 0.00 |
| SiBone (SIBN) | United States | $0.656B | 0.00 |
| AxoGen (AXGN) | United States | $0.652B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.541B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.511B | 4.11 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.501B | 8.84 |
| OrthoPediatrics (KIDS) | United States | $0.492B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.413B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.381B | 90.67 |
| Pacific Biosciences Of California (PACB) | United States | $0.363B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.359B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.348B | 8.85 |
| RxSight (RXST) | United States | $0.301B | 0.00 |
| NeuroPace (NPCE) | United States | $0.299B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.295B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.34 |
| Alpha Tau Medical (DRTS) | Israel | $0.276B | 0.00 |
| Neuronetics (STIM) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.232B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.223B | 0.00 |
| Inogen (INGN) | United States | $0.205B | 0.00 |
| CVRx (CVRX) | United States | $0.196B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.170B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.146B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.134B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.114B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| InspireMD (NSPR) | United States | $0.105B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.100B | 0.00 |
| Hyperfine (HYPR) | United States | $0.093B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.088B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| Spectral AI (MDAI) | United States | $0.056B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.051B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| DarioHealth (DRIO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.80 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |